OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity
- PMID: 16670306
- DOI: 10.4049/jimmunol.176.10.5975
OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity
Abstract
Signals through the OX40 costimulatory receptor on naive CD4 T cells are essential for full-fledged CD4 T cell activation and the generation of CD4 memory T cells. Because the ligand for OX40 is mainly expressed by APCs, including activated B cells, dendritic cells, and Langerhans cells, the OX40-OX40 ligand (OX40L) interaction has been thought to participate in T cell-APC interactions. Although several reports have revealed the expression of OX40L on T cells, the functional significance of its expression on them is still unclear. In this study, we demonstrate that Ag stimulation induced an increase in the surface expression and transcript levels of OX40L in CD4 T cells. Upon contact with OX40-expressing T cells, the cell surface expression of OX40L on CD4 T cells was markedly down-regulated, suggesting that OX40-OX40L binding occurs through a novel T cell-T cell interaction. To investigate the function of this phenomenon, we examined the proliferative response and survival of OX40L-deficient CD4 T cells when challenged with Ag. In vitro studies demonstrated markedly less CD3-induced proliferation of OX40L-deficient CD4 T cells compared with wild-type CD4 T cells. When using TCR transgenic CD4 T cells upon Ag stimulation, survival of OX40L-deficient T cells was impaired. Furthermore, we show that upon antigenic stimulation, fewer OX40L-deficient CD4 T cells than wild-type cells survived following transfer into wild-type and sublethally irradiated recipient mice. Taken together, our findings indicate that OX40L-expressing T cells have an autonomous machinery that provides OX40 signals through a T cell-T cell circuit, creating an additional mechanism for sustaining CD4 T cell longevity.
Similar articles
-
OX40, OX40L and Autoimmunity: a Comprehensive Review.Clin Rev Allergy Immunol. 2016 Jun;50(3):312-32. doi: 10.1007/s12016-015-8498-3. Clin Rev Allergy Immunol. 2016. PMID: 26215166 Review.
-
Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.J Immunol. 2004 Mar 15;172(6):3580-9. doi: 10.4049/jimmunol.172.6.3580. J Immunol. 2004. PMID: 15004159
-
Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.J Immunol. 2002 Oct 15;169(8):4628-36. doi: 10.4049/jimmunol.169.8.4628. J Immunol. 2002. PMID: 12370402
-
OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors.J Immunol. 2005 Feb 1;174(3):1433-7. doi: 10.4049/jimmunol.174.3.1433. J Immunol. 2005. PMID: 15661901
-
OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.Adv Immunol. 2010;105:63-98. doi: 10.1016/S0065-2776(10)05003-0. Adv Immunol. 2010. PMID: 20510730 Review.
Cited by
-
Adenoviral delivery of soluble ovine OX40L or CD70 costimulatory molecules improves adaptive immune responses to a model antigen in sheep.Front Cell Infect Microbiol. 2022 Sep 23;12:1010873. doi: 10.3389/fcimb.2022.1010873. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36211974 Free PMC article.
-
Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension.BMC Immunol. 2011 Dec 15;12:67. doi: 10.1186/1471-2172-12-67. BMC Immunol. 2011. PMID: 22171643 Free PMC article.
-
Current Clinical Trial Landscape of OX40 Agonists.Curr Oncol Rep. 2022 Jul;24(7):951-960. doi: 10.1007/s11912-022-01265-5. Epub 2022 Mar 29. Curr Oncol Rep. 2022. PMID: 35352295 Review.
-
OX40, OX40L and Autoimmunity: a Comprehensive Review.Clin Rev Allergy Immunol. 2016 Jun;50(3):312-32. doi: 10.1007/s12016-015-8498-3. Clin Rev Allergy Immunol. 2016. PMID: 26215166 Review.
-
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity.Acta Pharm Sin B. 2020 Mar;10(3):414-433. doi: 10.1016/j.apsb.2019.08.010. Epub 2019 Sep 3. Acta Pharm Sin B. 2020. PMID: 32140389 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous